Michael John Sumner
CIK 1936799 · View on SEC EDGAR ↗
Insider
First SEC filing: July 1, 2025 · Latest: July 1, 2025
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 25 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 30, 2025 | INO | M | 2,916 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-19) |
| June 30, 2025 | INO | M | 2,916 | — | — | 17,850 Direct | +19.53% | Acquired | (price as of 2026-08-19) |
| May 20, 2025 | INO | A | 35,100 | — | — | 35,100 Direct | — | Acquired | (price as of 2026-08-19) |
| May 20, 2025 | INO | A | 28,350 | — | — | 28,350 Direct | — | Acquired | (price as of 2026-08-19) |
| May 15, 2025 | INO | M | 2,385 | — | — | 2,385 Direct | -50.00% | Disposed | (price as of 2026-08-19) |
| May 15, 2025 | INO | F | 680 | $1.95 | $1,326 | 14,934 Direct | -4.36% | Disposed | -36.7% (price as of 2026-08-19) |
| May 15, 2025 | INO | M | 2,385 | — | — | 15,614 Direct | +18.03% | Acquired | (price as of 2026-08-19) |
| Feb. 27, 2025 | INO | A | 34,650 | — | — | 34,650 Direct | — | Acquired | (price as of 2026-08-19) |
| Feb. 27, 2025 | INO | A | 42,900 | — | — | 42,900 Direct | — | Acquired | (price as of 2026-08-19) |
| Feb. 26, 2025 | INO | M | 5,010 | — | — | 10,019 Direct | -33.34% | Disposed | (price as of 2026-08-19) |
| Feb. 26, 2025 | INO | M | 5,010 | — | — | 13,229 Direct | +60.96% | Acquired | (price as of 2026-08-19) |
| Dec. 18, 2024 | INO | A | 4,292 | — | — | 4,292 Direct | — | Acquired | (price as of 2026-08-19) |
| Dec. 18, 2024 | INO | A | 5,708 | — | — | 5,708 Direct | — | Acquired | (price as of 2026-08-19) |
| June 30, 2024 | INO | M | 2,917 | — | — | 2,916 Direct | -50.01% | Disposed | (price as of 2026-08-19) |
| June 30, 2024 | INO | M | 2,917 | — | — | 8,219 Direct | +55.02% | Acquired | (price as of 2026-08-19) |
| May 15, 2024 | INO | M | 2,386 | — | — | 4,770 Direct | -33.34% | Disposed | (price as of 2026-08-19) |
| May 15, 2024 | INO | M | 2,386 | — | — | 5,302 Direct | +81.82% | Acquired | (price as of 2026-08-19) |
| Feb. 28, 2024 | INO | A | 15,029 | — | — | 15,029 Direct | — | Acquired | (price as of 2026-08-19) |
| Feb. 28, 2024 | INO | A | 18,750 | — | — | 18,750 Direct | — | Acquired | (price as of 2026-08-19) |
| June 30, 2023 | INO | M | 35,000 | — | — | 70,000 Direct | -33.33% | Disposed | (price as of 2026-08-19) |
| June 30, 2023 | INO | M | 35,000 | — | — | 35,000 Direct | — | Acquired | (price as of 2026-08-19) |
| May 15, 2023 | INO | A | 85,878 | — | — | 85,878 Direct | — | Acquired | (price as of 2026-08-19) |
| Feb. 27, 2023 | INO | A | 112,500 | — | — | 112,500 Direct | — | Acquired | (price as of 2026-08-19) |
| June 30, 2022 | INO | A | 105,000 | — | — | 105,000 Direct | — | Acquired | (price as of 2026-08-19) |
| June 30, 2022 | INO | A | 160,000 | — | — | 160,000 Direct | — | Acquired | (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 30, 2025 | INO | Restricted Stock Unit | Common Stock (2,916) | — | — | 2,916 | Disposed |
| May 20, 2025 | INO | Common Stock Option | Common Stock (35,100) | $2.13 | May 20, 2035 | 35,100 | Acquired |
| May 20, 2025 | INO | Restricted Stock Unit | Common Stock (28,350) | — | — | 28,350 | Acquired |
| May 15, 2025 | INO | Restricted Stock Unit | Common Stock (2,385) | — | — | 2,385 | Disposed |
| Feb. 27, 2025 | INO | Restricted Stock Unit | Common Stock (34,650) | — | — | 34,650 | Acquired |
| Feb. 27, 2025 | INO | Common Stock Option | Common Stock (42,900) | $1.94 | Feb. 27, 2035 | 42,900 | Acquired |
| Feb. 26, 2025 | INO | Restricted Stock Unit | Common Stock (5,010) | — | — | 5,010 | Disposed |
| Dec. 18, 2024 | INO | Restricted Stock Unit | Common Stock (4,292) | — | — | 4,292 | Acquired |
| Dec. 18, 2024 | INO | Common Stock Option | Common Stock (5,708) | $1.78 | Dec. 18, 2034 | 5,708 | Acquired |
| June 30, 2024 | INO | Restricted Stock Unit | Common Stock | — | — | 2,917 | Disposed |
| May 15, 2024 | INO | Restricted Stock Unit | Common Stock | — | — | 2,386 | Disposed |
| Feb. 28, 2024 | INO | Restricted Stock Unit | Common Stock (15,029) | — | — | 15,029 | Acquired |
| Feb. 28, 2024 | INO | Common Stock Option | Common Stock (18,750) | $8.46 | Feb. 28, 2034 | 18,750 | Acquired |
| June 30, 2023 | INO | Restricted Stock Unit | Common Stock (35,000) | — | — | 35,000 | Disposed |
| May 15, 2023 | INO | Restricted Stock Unit | Common Stock (85,878) | — | — | 85,878 | Acquired |
| Feb. 27, 2023 | INO | Common Stock Option | Common Stock (112,500) | $1.24 | Feb. 27, 2033 | 112,500 | Acquired |
| June 30, 2022 | INO | Restricted Stock Unit | Common Stock (105,000) | — | — | 105,000 | Acquired |
| June 30, 2022 | INO | Common Stock Options | Common Stock (160,000) | $1.73 | June 30, 2032 | 160,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
INO
M.D. Chief Medical Officer and Head of Development| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $548,708 | — | $127,607 | $129,554 | $87,392 | — | $17,375 | $910,636 |
| 2024 | $532,000 | $47,133 | $139,596 | $136,320 | $167,107 | — | $15,250 | $1,037,406 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.